Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection.

Yannoutsos N, Ijzermans JN, Harkes C, Bonthuis F, Zhou CY, White D, Marquet RL, Grosveld F.

Genes Cells. 1996 Apr;1(4):409-19. Erratum in: Genes Cells 1996 Aug;1(8):785.

2.

A human CD46 transgenic pig model system for the study of discordant xenotransplantation.

Diamond LE, Quinn CM, Martin MJ, Lawson J, Platt JL, Logan JS.

Transplantation. 2001 Jan 15;71(1):132-42.

PMID:
11211178
3.

An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.

Mora M, Lazzer M, Marsicano G, Mulder LC, Carraresi L, Pieri A, Benanchi A, Grifoni D, Nuti S, Bruzzone P, Comporti M, Cortesini R, Rossini M.

Transgenic Res. 2000 Jun;9(3):205-13.

PMID:
11032369
4.

Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.

Lazzeri M, Mora M, Mulder LC, Marsicano G, Marinucci G, Boschi M, Bruzzone P, Alfani D, Cortesini R, Rossini M.

J Urol. 1998 Apr;159(4):1364-9.

PMID:
9507885
5.

Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection.

Thorley BR, Milland J, Christiansen D, Lanteri MB, McInnes B, Moeller I, Rivailler P, Horvat B, Rabourdin-Combe C, Gerlier D, McKenzie IF, Loveland BE.

Eur J Immunol. 1997 Mar;27(3):726-34.

PMID:
9079815
6.

Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.

Fodor WL, Williams BL, Matis LA, Madri JA, Rollins SA, Knight JW, Velander W, Squinto SP.

Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11153-7.

7.

Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.

Loveland BE, Milland J, Kyriakou P, Thorley BR, Christiansen D, Lanteri MB, Regensburg M, Duffield M, French AJ, Williams L, Baker L, Brandon MR, Xing PX, Kahn D, McKenzie IF.

Xenotransplantation. 2004 Mar;11(2):171-83.

PMID:
14962279
8.

Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII.

Lanteri MB, Powell MS, Christiansen D, Li YQ, Hogarth M, Sandrin MS, Mckenzie IF, Loveland BE.

Transplantation. 2000 Mar 27;69(6):1128-36.

PMID:
10762218
9.

Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.

McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL.

Transplantation. 1995 Apr 27;59(8):1177-82.

PMID:
7537395
10.

The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.

Fisicaro N, Aminian A, Hinchliffe SJ, Morgan BP, Pearse MJ, D'Apice AJ, Cowan PJ.

Transplantation. 2000 Sep 27;70(6):963-8.

PMID:
11014650
11.

Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.

Cary N, Moody J, Yannoutsos N, Wallwork J, White D.

Transplant Proc. 1993 Feb;25(1 Pt 1):400-1. No abstract available.

PMID:
7679815
12.

A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation.

Kroshus TJ, Salerno CT, Yeh CG, Higgins PJ, Bolman RM 3rd, Dalmasso AP.

Transplantation. 2000 Jun 15;69(11):2282-9.

PMID:
10868627
13.

Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejection.

Verbakel CA, Bonthuis F, Eerhart SE, van Dixhoorn M, Grosveld F, Marquet RL, IJzermans JN.

Transplant Proc. 2000 Aug;32(5):903-4. No abstract available.

PMID:
10936266
14.

Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.

Shinkel TA, Cowan PJ, Barlow H, Aminian A, Romanella M, Lublin DM, Pearse MJ, d'Apice AJ.

Transplantation. 1998 Dec 15;66(11):1401-6.

PMID:
9869079
15.

Human CD46 but not CD59 in transgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serum.

Marquet RL, van Stijn I, van den Tol PM, Bonthuis F, Yannoutsos N, IJzermans JN.

Transplant Proc. 1997 Feb-Mar;29(1-2):931-2. No abstract available.

PMID:
9123592
16.

Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes.

Wu G, Pfeiffer S, Schröder C, Zhang T, Nguyen BN, Kelishadi S, Atkinson JB, Schuurman HJ, White DJ, Azimzadeh AM, Pierson RN 3rd.

Xenotransplantation. 2007 Jan;14(1):34-47.

PMID:
17214703
17.

Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.

White DJ, Oglesby T, Liszewski MK, Tedja I, Hourcade D, Wang MW, Wright L, Wallwork J, Atkinson JP.

Transpl Int. 1992;5 Suppl 1:S648-50.

PMID:
14621899
18.

Human membrane cofactor protein (MCP, CD 46) protects transgenic pig hearts from hyperacute rejection in primates.

Adams DH, Kadner A, Chen RH, Farivar RS.

Xenotransplantation. 2001 Feb;8(1):36-40.

PMID:
11208189
19.
20.

Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells.

van den Berg CW, Rix C, Hanna SM, Perez de la Lastra JM, Morgan BP.

Transplantation. 2000 Aug 27;70(4):667-73.

PMID:
10972227

Supplemental Content

Support Center